We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana (HUM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Read MoreHide Full Article
For the quarter ended March 2023, Humana (HUM - Free Report) reported revenue of $26.74 billion, up 11.6% over the same period last year. EPS came in at $9.38, compared to $8.04 in the year-ago quarter.
The reported revenue represents a surprise of +1.61% over the Zacks Consensus Estimate of $26.32 billion. With the consensus EPS estimate being $9.25, the EPS surprise was +1.41%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Humana performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Benefits Expense Ratio - Consolidated: 85.5% compared to the 86.26% average estimate based on seven analysts.
Medical Membership - ASO commercial: 414.8 thousand compared to the 346.85 thousand average estimate based on five analysts.
Medical Membership - Fully-insured commercial medical: 522.6 thousand versus 441.03 thousand estimated by five analysts on average.
Medical Membership - Medicare stand-alone PDP: 2956.3 thousand versus 3381.57 thousand estimated by five analysts on average.
Revenues- Services: $999 million versus the seven-analyst average estimate of $955.24 million.
Revenues- Premiums: $25.55 billion versus the seven-analyst average estimate of $25.10 billion.
Revenues- Investment income (loss): $193 million versus the six-analyst average estimate of $179.54 million. The reported number represents a year-over-year change of +6333.3%.
Revenues- Consolidated- Premiums- Medicaid and other: $1.91 billion compared to the $1.94 billion average estimate based on five analysts. The reported number represents a change of +22.8% year over year.
Revenues- Consolidated- Premiums- Medicare stand-alone PDP: $616 million compared to the $547.14 million average estimate based on five analysts. The reported number represents a change of -3.6% year over year.
Revenues- Consolidated- Premiums- Individual Medicare Advantage: $19.81 billion compared to the $19.50 billion average estimate based on five analysts. The reported number represents a change of +16.2% year over year.
Revenues- Consolidated- Premiums- Group Medicare Advantage: $1.77 billion compared to the $1.81 billion average estimate based on five analysts. The reported number represents a change of -5.9% year over year.
Revenues- Consolidated- Services revenue- Provider Services: $201 million versus the four-analyst average estimate of $158.79 million. The reported number represents a year-over-year change of +77.9%.
Shares of Humana have returned +4.1% over the past month versus the Zacks S&P 500 composite's +2.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Humana (HUM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2023, Humana (HUM - Free Report) reported revenue of $26.74 billion, up 11.6% over the same period last year. EPS came in at $9.38, compared to $8.04 in the year-ago quarter.
The reported revenue represents a surprise of +1.61% over the Zacks Consensus Estimate of $26.32 billion. With the consensus EPS estimate being $9.25, the EPS surprise was +1.41%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Humana performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Benefits Expense Ratio - Consolidated: 85.5% compared to the 86.26% average estimate based on seven analysts.
- Medical Membership - ASO commercial: 414.8 thousand compared to the 346.85 thousand average estimate based on five analysts.
- Medical Membership - Fully-insured commercial medical: 522.6 thousand versus 441.03 thousand estimated by five analysts on average.
- Medical Membership - Medicare stand-alone PDP: 2956.3 thousand versus 3381.57 thousand estimated by five analysts on average.
- Revenues- Services: $999 million versus the seven-analyst average estimate of $955.24 million.
- Revenues- Premiums: $25.55 billion versus the seven-analyst average estimate of $25.10 billion.
- Revenues- Investment income (loss): $193 million versus the six-analyst average estimate of $179.54 million. The reported number represents a year-over-year change of +6333.3%.
- Revenues- Consolidated- Premiums- Medicaid and other: $1.91 billion compared to the $1.94 billion average estimate based on five analysts. The reported number represents a change of +22.8% year over year.
- Revenues- Consolidated- Premiums- Medicare stand-alone PDP: $616 million compared to the $547.14 million average estimate based on five analysts. The reported number represents a change of -3.6% year over year.
- Revenues- Consolidated- Premiums- Individual Medicare Advantage: $19.81 billion compared to the $19.50 billion average estimate based on five analysts. The reported number represents a change of +16.2% year over year.
- Revenues- Consolidated- Premiums- Group Medicare Advantage: $1.77 billion compared to the $1.81 billion average estimate based on five analysts. The reported number represents a change of -5.9% year over year.
- Revenues- Consolidated- Services revenue- Provider Services: $201 million versus the four-analyst average estimate of $158.79 million. The reported number represents a year-over-year change of +77.9%.
View all Key Company Metrics for Humana here>>>Shares of Humana have returned +4.1% over the past month versus the Zacks S&P 500 composite's +2.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.